View |
|
DR-XY 48101
|
Vancomycin Hydrochloride
|
Vancover
|
125 mg
|
Capsule
|
Antibacterial (Glycopepure
|
Orient Pharma Co., Ltd.
|
Taiwan
|
Monitored Release
|
09 June 2022
|
09 June 2025
|
View |
|
DR-XY 48110
|
Cyproterone Acetate + Ethinylestradiol
|
Cypress
|
2 mg/35 mcg
|
Tablet
|
Antiandrogen-Estrogen Combination (Hormonal Contraceptive)
|
Mylan Laboratories Ltd.
|
India
|
Initial
|
16 June 2022
|
16 June 2027
|
View |
|
DR-XY 48176
|
Lenalidomide
|
Linadex 25
|
25 mg
|
Capsule
|
Immunosuppressant
|
Hetero Labs Limited (Unit-V, Block-VB)
|
India
|
Monitored Release
|
11 July 2022
|
11 July 2025
|
View |
|
DR-XY 48288
|
Fenofibric Acid
|
None
|
105 mg
|
Softgel Capsule
|
Lipid Modifying Agent
|
Amherst Laboratories, Inc.
|
Philippines
|
Monitored Release (Re-application)
|
15 August 2022
|
15 August 2027
|
View |
|
DR-XY 48289
|
Aciclovir + Hydrocortisone
|
None
|
50 mg/10 mg per gram (5%/1% w/w)
|
Topical Cream
|
Antiviral-Corticosteroid Combination
|
Asian Antibiotics, Inc.
|
Philippines
|
Monitored Release (Re-application)
|
15 August 2022
|
15 August 2027
|
View |
|
DR-XY 48652
|
Candesartan cilexetil
|
Hyperest
|
8 mg
|
Tablet
|
-
|
Laboratorios Liconsa, S.A.
|
|
Initial
|
24 March 2023
|
24 March 2028
|
View |
|
DR-XY 48778
|
Omeprazole (as sodium monohydrate).
|
Fluxzol
|
40 mg
|
Lyophilized Powder for Intravenous Injection
|
Proton Pump Inhibitor
|
Reyoung Pharmaceutical Co., Ltd.
|
China
|
Initial
|
22 June 2023
|
22 June 2028
|
View |
|
DR-XY 48782
|
Propofol
|
Parafol
|
10 mg/mL (1% w/v)
|
Emulsion for Intravenous Injection
|
General Anesthetic
|
Dongkook Pharmaceutical Co., Ltd.
|
Korea
|
Initial
|
23 June 2023
|
23 June 2028
|
View |
|
DR-XY 48965
|
Carboplatin
|
Platixon
|
450 mg/45 mL (10 mg/mL)
|
Solution for Intravenous
Infusion
|
Antineoplastic Agent
|
Venus Remedies Limited
|
India
|
Initial
|
28 December 2023
|
28 December 2028
|
View |
|
DR-XY 48966
|
Carboplatin
|
Platixon
|
150 mg/15 mL (10 mg/mL)
|
Solution for Intravenous
Infusion
|
Antineoplastic Agent
|
Venus Remedies Limited
|
India
|
Initial
|
28 December 2023
|
28 December 2028
|
View |
|
DR-XY 49015
|
Bupivacaine hydrochloride
|
Bucain Spinal Heavy
|
5 mg/mL (0.5% w/v)
|
Solution for Intrathecal Injection
|
Local Anesthetic (Amide)
|
PT. Bernofarm
|
Indonesia
|
Initial
|
05 March 2024
|
08 March 2029
|
View |
|
DR-XY 49016
|
Bupivacaine hydrochloride
|
Porsvacaine
|
5 mg/mL (0.5% w/v)
|
Solution for Injection (Epidural, Intraarticular, Subcutaneous or Perineural)
|
Local Anesthetic (Amide)
|
Med Biopharm Pvt. Ltd.
|
India
|
Initial
|
08 March 2024
|
08 March 2029
|
View |
|
DR-XY 49093
|
Ticagrelor
|
Medglor 90
|
90 mg
|
Film-Coated Tablet
|
Antithrombotic Agent (Platelet Aggregation Inhibitor)
|
Exemed Pharmaceuticals
|
India
|
Initial
|
24 May 2024
|
24 May 2029
|
View |
|
DR-XY-21457
|
Albendazole
|
Zentel
|
400 mg/10 mL
|
Suspension
|
-
|
SmithKline Beecham
|
Philippines
|
-
|
29 September 2021
|
13 January 2025
|
View |
|
DR-XY092
|
Policresulen+Cinchocaine hydrochloride
|
Faktu
|
100mg/2.5mg
|
Suppository
|
Antihemorrhoidal
|
|
|
Renewal
|
29 June 2024
|
06 October 2029
|
View |
|
DR-XY093
|
Policresulen+Cinchocaine HCl
|
Faktu
|
50mg/10mg per gram
|
Ointment
|
Antihemorrhoidal
|
Takeda GmbH
|
Germany
|
Renewal
|
12 June 2024
|
03 August 2029
|
View |
|
DR-XY10007
|
Diphenhydramine Hydrochloride
|
None
|
12.5 mg/ 5 mL
|
Elixir
|
-
|
Am-Europharma Corporation
|
Philippines
|
-
|
03 February 2021
|
24 January 2026
|
View |
|
DR-XY10009-B
|
Dicycloverine Hydrochloride
|
None
|
10 mg/5 mL
|
Syrup
|
-
|
Am-Europharma Corporation
|
Philippines
|
-
|
26 June 2020
|
05 July 2025
|
View |
|
DR-XY10083
|
Mefenamic Acid
|
Mefenax
|
500 mg
|
Tablet
|
-
|
Hizon Laboratories, Inc.
|
Philippines
|
Automatic Renewal (Reconstruction)
|
15 September 2022
|
27 September 2025
|
View |
|
DR-XY10086
|
Amoxicillin (As Trihydrate)
|
ELEOMOX
|
500 mg
|
Capsule
|
Antibacterial (Penicillin)
|
Lloyd Laboratories, Inc.
|
Philippines
|
Automatic Renewal
|
17 March 2022
|
10 April 2027
|